These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26561550)

  • 1. Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice.
    Otomo K; Koga T; Mizui M; Yoshida N; Kriegel C; Bickerton S; Fahmy TM; Tsokos GC
    J Immunol; 2015 Dec; 195(12):5533-7. PubMed ID: 26561550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.
    Koga T; Sato T; Furukawa K; Morimoto S; Endo Y; Umeda M; Sumiyoshi R; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Origuchi T; Nakamura H; Kawakami A
    Arthritis Rheumatol; 2019 May; 71(5):766-772. PubMed ID: 30462889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis.
    Kono M; Yoshida N; Maeda K; Suárez-Fueyo A; Kyttaris VC; Tsokos GC
    Arthritis Rheumatol; 2019 Nov; 71(11):1869-1878. PubMed ID: 31233276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice.
    Koga T; Mizui M; Yoshida N; Otomo K; Lieberman LA; Crispín JC; Tsokos GC
    Autoimmunity; 2014 Nov; 47(7):445-50. PubMed ID: 24829059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL/lpr mice by inhibiting expression of Ca(2+)/calmodulin-dependent protein kinase-4.
    Shui B; Xia W; Wen C; Ding X
    J Nat Med; 2015 Jul; 69(3):349-57. PubMed ID: 25821132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TARGETING TARGETED TREATMENT FOR IMMUNE AND NON-IMMUNE KIDNEY DISEASES.
    Tsokos GC; Tsokos MG
    Trans Am Clin Climatol Assoc; 2019; 130():88-99. PubMed ID: 31516171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV.
    Ichinose K; Juang YT; Crispín JC; Kis-Toth K; Tsokos GC
    Arthritis Rheum; 2011 Feb; 63(2):523-9. PubMed ID: 20954187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation.
    Zhao M; Tan Y; Peng Q; Huang C; Guo Y; Liang G; Zhu B; Huang Y; Liu A; Wang Z; Li M; Gao X; Wu R; Wu H; Long H; Lu Q
    Nat Commun; 2018 Feb; 9(1):583. PubMed ID: 29422534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation.
    Kono M; Maeda K; Stocton-Gavanescu I; Pan W; Umeda M; Katsuyama E; Burbano C; Orite SYK; Vukelic M; Tsokos MG; Yoshida N; Tsokos GC
    JCI Insight; 2019 Jun; 4(12):. PubMed ID: 31217348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
    Lee J; Choi J; Lee W; Ko K; Kim S
    Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of human and mouse Th17 differentiation and autoimmunity by an endogenous Interleukin 23 receptor cytokine-binding homology region.
    Guo W; Luo C; Wang C; Wang YH; Wang X; Gao XD; Yao WB
    Int J Biochem Cell Biol; 2014 Oct; 55():304-10. PubMed ID: 25263529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.
    Hou LF; He SJ; Li X; Yang Y; He PL; Zhou Y; Zhu FH; Yang YF; Li Y; Tang W; Zuo JP
    Arthritis Rheum; 2011 Aug; 63(8):2445-55. PubMed ID: 21484768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK inhibitors suppress Th17 and promote iTreg differentiation, and ameliorate experimental autoimmune encephalomyelitis in mice.
    Yoshida H; Kotani H; Kondo T; Tani I; Wei X; Tsuruta S; Kimura A; Asakawa M; Ito M; Nagai S; Yoshimura A
    Biochem Biophys Res Commun; 2013 Jun; 435(3):378-84. PubMed ID: 23665028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation.
    Yoshida H; Kimura A; Fukaya T; Sekiya T; Morita R; Shichita T; Inoue H; Yoshimura A
    Biochem Biophys Res Commun; 2012 Feb; 418(2):234-40. PubMed ID: 22252297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis.
    Othy S; Hegde P; Topçu S; Sharma M; Maddur MS; Lacroix-Desmazes S; Bayry J; Kaveri SV
    J Immunol; 2013 May; 190(9):4535-41. PubMed ID: 23526819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.
    Koga T; Hedrich CM; Mizui M; Yoshida N; Otomo K; Lieberman LA; Rauen T; Crispín JC; Tsokos GC
    J Clin Invest; 2014 May; 124(5):2234-45. PubMed ID: 24667640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-1BB triggering ameliorates experimental autoimmune encephalomyelitis by modulating the balance between Th17 and regulatory T cells.
    Kim YH; Choi BK; Shin SM; Kim CH; Oh HS; Park SH; Lee DG; Lee MJ; Kim KH; Vinay DS; Kwon BS
    J Immunol; 2011 Aug; 187(3):1120-8. PubMed ID: 21715692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-associated changes in rat immune system: lessons learned from experimental autoimmune encephalomyelitis.
    Djikić J; Nacka-Aleksić M; Pilipović I; Stojić-Vukanić Z; Bufan B; Kosec D; Dimitrijević M; Leposavić G
    Exp Gerontol; 2014 Oct; 58():179-97. PubMed ID: 25128713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.